EF Hutton analyst Michael Albanese reiterates Odyssey Marine Explr (NASDAQ:OMEX) with a Buy and maintains $7.5 price target.
EF Hutton Reiterates Buy on Odyssey Marine Explr, Maintains $7.5 Price Target
EF Hutton analyst Michael Albanese reiterates Odyssey Marine Explr (NASDAQ:OMEX) with a Buy and maintains $7.5 price target.
Related Posts
Ascendis Pharma A/S Announces U.S. Food and Drug Administration Approval of SKYTROFA® (lonapegsomatropin-tcgd), the First Once-weekly Treatment for Pediatric Growth Hormone Deficiency
SKYTROFA, the first FDA approved treatment utilizing TransCon™ technology, is a long-acting prodrug of somatropin that releases the same somatropin used in daily therapies –
- Once weekly
ADT Q4 EPS $(0.03) Up From $(0.12) YoY, Sales $1.40B Beat $1.32B Estimate
ADT (NYSE:ADT) reported quarterly losses of $(0.03) per share. This is a 75 percent increase over losses of $(0.12) per share from the same period last year. The company reported quarterly sales of $1.40 billion which